Teva Slumps as 2026 Revenue Outlook Falls Short of Expectations
Teva Pharmaceuticals Inc. fell Wednesday after its 2026 revenue forecast was weaker than Wall Street expected.
By Jessica Nix ยท Bloomberg Markets
Teva Pharmaceuticals Inc. fell Wednesday after its 2026 revenue forecast was weaker than Wall Street expected.